ACTG announces publication of REPRIEVE sub-study in JAMA Network Open, providing insights into cardiovascular disease risk among people living with HIV

Los Angeles, Calif. – The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, today announced that findings from a sub-study of REPRIEVE (A5332/A5332s, an international clinical trial studying heart disease prevention in people living with HIV) have been published in the Journal of the American Medical Association Network Open (JAMA Network Open).…

Details

Gin from Cachaça Country

Gin, made around the world, comes in two basic styles: austere, juniper-forward London dry, and a more aromatic herbal or floral version. For a martini and perhaps even with tonic, it’s the London dry you’ll want and, more specifically, this alluringly subtle Brazilian gin, Amázzoni, newly available in the United States. It leans on botanicals…

Details

Mixing Pfizer, AstraZeneca Vaccines Gives Strong Covid Protection, Study Finds

Early results from a British vaccine study suggest that mixing different brands of vaccines can provoke a protective immune response against Covid-19. In the trial, volunteers produced high levels of antibodies and immune cells after getting one dose of the Pfizer-BioNTech vaccine and one dose of the AstraZeneca-Oxford shot. Administering the vaccines in either order…

Details